Clinical Trials Logo

Exclusive Enteral Nutrition clinical trials

View clinical trials related to Exclusive Enteral Nutrition.

Filter by:
  • None
  • Page 1

NCT ID: NCT04999241 Not yet recruiting - Ulcerative Colitis Clinical Trials

Combined Application of EEN in the Induction of Remission in PUC

Start date: March 1, 2024
Phase: Phase 4
Study type: Interventional

The role of exclusive enteral nutrition (EEN) in the induction of remission in pediatric patients with Crohn's disease had been well documented. But the role of EEN in children with Ulcerative Colitis (UC) was not clear. In this study, EEN will be combined with corticosteroids or infliximab in the induction of remission in pediatric UC patients with moderate to severe disease activity. The mucosal healing rate at week12 will be compared between the two groups (combine with EEN group VS non-combine group).

NCT ID: NCT04530877 Withdrawn - Crohn's Disease Clinical Trials

Exclusive Enteral Nutrition vs. Infliximab in Chinese CD Patients

Start date: October 1, 2022
Phase: Phase 4
Study type: Interventional

prospectively compared Exclusive Enteral Nutrition with Infliximab in the clinical outcomes, mucosal healing, nutrition improvements, adverse effects and gastrointestinal microbiota changes on Chinese Children With active Crohn's Disease